Reuters logo
BRIEF-Ipsen receives positive CHMP opinion for approval of Xermelo‍​
July 21, 2017 / 6:40 AM / 5 months ago

BRIEF-Ipsen receives positive CHMP opinion for approval of Xermelo‍​

July 21 (Reuters) - IPSEN SA:

* RECEIVES POSITIVE CHMP OPINION FOR APPROVAL OF XERMELO‍​

* POSITIVE OPINION BASED ON RESULTS OF TWO RANDOMIZED PHASE 3 TRIALS, TELESTAR AND TELECAST

* APPROVAL FOR TREATMENT OF CARCINOID SYNDROME DIARRHEA IN PATIENTS INADEQUATELY CONTROLLED BY SOMATOSTATIN ANALOGUE THERAPY‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below